IDEXX Laboratories (UK) Performance
| 0J8P Stock | 434.17 3.78 0.86% |
The company retains a Market Volatility (i.e., Beta) of 0.39, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IDEXX Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding IDEXX Laboratories is expected to be smaller as well. At this point, IDEXX Laboratories has a negative expected return of -0.22%. Please make sure to check out IDEXX Laboratories' mean deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if IDEXX Laboratories performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Toronto Dominion Bank Sells 7,672 Shares of IDEXX Laboratories, Inc. - MarketBeat | 09/27/2024 |
2 | At US420, Is It Time To Put IDEXX Laboratories, Inc. On Your Watch List - Simply Wall St | 11/19/2024 |
3 | Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues - MSN | 12/11/2024 |
| Begin Period Cash Flow | 112.5 M |
IDEXX |
IDEXX Laboratories Relative Risk vs. Return Landscape
If you would invest 50,802 in IDEXX Laboratories on September 16, 2024 and sell it today you would lose (7,385) from holding IDEXX Laboratories or give up 14.54% of portfolio value over 90 days. IDEXX Laboratories is generating negative expected returns and assumes 1.7454% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than IDEXX, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
IDEXX Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IDEXX Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IDEXX Laboratories, and traders can use it to determine the average amount a IDEXX Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1275
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0J8P |
Estimated Market Risk
| 1.75 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average IDEXX Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IDEXX Laboratories by adding IDEXX Laboratories to a well-diversified portfolio.
IDEXX Laboratories Fundamentals Growth
IDEXX Stock prices reflect investors' perceptions of the future prospects and financial health of IDEXX Laboratories, and IDEXX Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IDEXX Stock performance.
| Return On Equity | 0.59 | ||||
| Return On Asset | 0.23 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.37 % | ||||
| Current Valuation | 36.24 B | ||||
| Shares Outstanding | 86.23 M | ||||
| Price To Sales | 9.73 X | ||||
| Revenue | 3.66 B | ||||
| Gross Profit | 2 B | ||||
| EBITDA | 1.22 B | ||||
| Net Income | 845.04 M | ||||
| Total Debt | 1.07 B | ||||
| Book Value Per Share | 19.72 X | ||||
| Cash Flow From Operations | 906.51 M | ||||
| Earnings Per Share | 8.52 X | ||||
| Total Asset | 3.26 B | ||||
| Retained Earnings | 4.44 B | ||||
About IDEXX Laboratories Performance
Assessing IDEXX Laboratories' fundamental ratios provides investors with valuable insights into IDEXX Laboratories' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IDEXX Laboratories is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
IDEXX Laboratories is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about IDEXX Laboratories performance evaluation
Checking the ongoing alerts about IDEXX Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IDEXX Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| Over 94.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues - MSN |
- Analyzing IDEXX Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IDEXX Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining IDEXX Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IDEXX Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IDEXX Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IDEXX Laboratories' stock. These opinions can provide insight into IDEXX Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.